Brokerages Set Aspen Aerogels, Inc. (NYSE:ASPN) Price Target at $15.50

Aspen Aerogels, Inc. (NYSE:ASPN) has been assigned a consensus recommendation of “Hold” from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $15.50.

Several equities research analysts have weighed in on the stock. Weiss Ratings restated a “sell (d)” rating on shares of Aspen Aerogels in a research note on Friday. Canaccord Genuity Group lowered their target price on shares of Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating for the company in a research note on Friday, August 8th. Finally, Barclays downgraded shares of Aspen Aerogels from an “equal weight” rating to an “underweight” rating and raised their target price for the company from $7.00 to $16.00 in a research note on Monday, August 11th.

Insiders Place Their Bets

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the firm’s stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the completion of the sale, the chief accounting officer directly owned 19,879 shares in the company, valued at $145,315.49. This trade represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 4.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors have recently bought and sold shares of the company. Nisa Investment Advisors LLC lifted its stake in shares of Aspen Aerogels by 1,094.8% during the second quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company’s stock worth $28,000 after buying an additional 4,390 shares during the period. SBI Securities Co. Ltd. lifted its stake in shares of Aspen Aerogels by 67.3% during the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock worth $38,000 after buying an additional 2,551 shares during the period. Tower Research Capital LLC TRC lifted its stake in shares of Aspen Aerogels by 184.6% during the second quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock worth $43,000 after buying an additional 4,693 shares during the period. Acadian Asset Management LLC acquired a new stake in shares of Aspen Aerogels during the first quarter worth $43,000. Finally, Banque Cantonale Vaudoise acquired a new stake in shares of Aspen Aerogels during the first quarter worth $45,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Stock Performance

Shares of ASPN stock opened at $8.47 on Wednesday. The firm has a market cap of $697.92 million, a price-to-earnings ratio of -2.22 and a beta of 2.80. The company’s 50 day moving average is $7.28 and its 200 day moving average is $6.63. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. Aspen Aerogels has a 52-week low of $4.16 and a 52-week high of $20.19.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.08. The company had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. Aspen Aerogels’s revenue was down 33.8% compared to the same quarter last year. During the same period last year, the company posted $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860–3.730 EPS. On average, sell-side analysts anticipate that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.